Home » ... » Molecular and Enviro Toxicology » - Current Students » Park, Heesoo
- Current Students
Student Resources
Student Publications
Blanke, Kristina
Boley, Patricia
Bolterstein, Elyse
Booth, Clarissa
Brody, Matthew
Bultman, JoAnna
Burns, Felipe
Desotelle, Josh
Ding, Lina
Elmergreen, Tammy
Hutchinson, John
Irving, Amy
Irving, Roy
Johnson, Brian
Johnson, Delinda
Johnson, Shaina
Jung-Hynes, Brittney
Kumar, Kartik
Lee, Sung-Kyoung
Lorch, Jeff
Mehta, Vatsal
Novick, Rachel
Park, Heesoo
Pham, Ly
Poenitzsch, Ashley
Rhoads, Keelia
Rufer, Echoleah
Sand, Jordan
Schmit, Travis
Shan, Weihua
Shanle, Erin
Shetty, Ameesha
Syed, Deeba
Tarapore, Rohinton
Velasco, Javier
Wiecinski, Paige
Wong, Letitia
Yang, Sarah
Yu, Min
Zhao, Yun
Calkins, Marcus
Park, Heesoo

Heesoo Park - Email
PhD Candidate - Started Fall 2008
Seoul, Korea
Lab of Jaehyuk Yu, PhD

Undergraduate & Graduate Work
2006 - Masters in Life Sciences with Handong Global University; Kyungbak, Korea
2004 - BS in Life and Food Science from Handong Global University; Kyungbak, Korea

Work Experienc
2006-07 - CystalGenmics, Inc Seoul, Korea
2007-08 - The Institute for Biomedical Research - Handong University

Interests

Why I Joined METC

Publications
  • Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH. CG400462, a new bacterial enoyl-acyl carrier protein reductase (FabI) Inhibitor. Int J Antimicrob Agents Accepted: 2007 Nov:30(5):446-451
  • Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J Antimicrob Chemother. 2007 Sep;60:568-574
  • Park HS, Kim HJ, Seol MJ, Choi DR, Choi EC, Kwak JH. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob Agents Chemother. 2006 Jun;50(6):2261-2264.
  • Kim HJ, Seol MJ, Park HS, Choi DR, Seong SK, Shin HK, Kwak JH. Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae. J Antimicrob Chemother. 2006 Jun;57(6):1256-8.


Posters
  • M. J. Seol, H. J. Kim, H. S. Park, D. R. Choi, Y. Jung, and J. H. Kwak In vitro and In vivo Antibacterial Activities of the New Fluoroquinolone, DW-224a. 43th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2003.
  • M. J. Seol, H. J. Kim, H. S. Park, D. R. Choi, and J. H. Kwak. Characterization of mutations in DNA gyrase and topoisomerase ‡W involved in resistant mutants to DW-286a, a novel quinolone antibiotic, in Streptococcus pneumoniae. Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2003
  • H. J. Kim, M. J. Seol, H. S. Park, J. K Lee, S. Y. Choi and J. H. Kwak. Screening of new antibiotics inhibiting bacterial peptide deformylase. Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2003
  • M. J. Seol, H. J. Kim, H. S. Park, D. R. Choi, Y. Jung, and J. H. Kwak. Bactericidal Activities of DW-224a, a New Fluoroquinolone. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2004.
  • H. S. Park, Y. M. Yoon, S. J. Jung, D. R. Choi, and J. H. Kwak. In vitro and In vivo antibacterial activity of DW-224a against susceptible and resistant Gram positive organism. 5th International Symposium on Antimicrobial Agents and Resistance Asian-Pacific Research Foundation for Infectious Diseases, 2005
  • H. S. Park, S. J. Jung, Y. M. Yoon, D. R. Choi, and J. H. Kwak. DNA Gyrase and Topoisomerase ‡W Are Dual Targets of DW-224a in Streptococcus pneumoniae Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2005
  • H. S. Park, S. J. Jung, D. R. Choi, and J. H. Kwak. In Vitro and In Vivo Efficacy of a New Fluoronaphthyridone, DW-224a, against Streptococcus pneumoniae. Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2005
  • C. M. Kim, J. H. Kwak, Y. S. Kim, H. J. Yoon, H. S. Park, J. M. Kim, Y. M. Song, Y. E. Kim, Y. L Hyun, S. G. Ro, T. G. Lee and J. M Cho. Antimicrobial activity of CG400549 tested against clinically isolated MRSA strain. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2005.
  • C. M. Kim, J. M. Kim, Y. M. Song, C. S. Lee, H. S. Park, S. K. Kang, J. H. Kwak, Y. S. Huh. D. G. Shin, S. G. Ro, T. G. Lee and J. M Cho. CG400549, a novel FabI inhibitor with potent in vitro activity. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2005.
  • C. M. Kim, Y. S. Kim, J. H. Kwak, H. J. Yoon, H. S. Park, J. M. Kim, S. G. Ro, T. G. Lee and J. M Cho. Time-kill kinetics, Post-antibiotic effect and mutation frequency of CG400549. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2005
  • H. S. Park, C. M. Kim, Y M. Yoon, S. J. Jung. I. N. R. Yun, J. M. Kim, S. G. Ro, J. M. Cho J. H. Kwak. In vitro and in vivo activity of CG4000549, a novel FabI inhibitor, against QRSA. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2006
  • H. S. Park, C. M. Kim, Y. M. Yoon, S. J. Jung, I. N. R. Yun, J. M. Kim, S. G. Ro, J. H. Kwak. Antistaphylococcal Activities of CG400462, Novel FabI Inhibitors. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2006
  • H. S. Park, Y. M. Yoon, S. J. Jung. D. R. Choi, J. M. Ryo. J. H. Kwak. DNA gyras and topoisomerase ‡W are dual targets of DW-224a, a new fluoroquinolone, in Streptococcus pneumoniae. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2006
  • S. J. Jung, I. N. R. Yun, H. S. Park, S. H. Woo, J. H. Kwak. In Vitro Activity of LCB01-0062, Novel Oxazolidinones against Gram Positive Cocci. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2007.


Date Last Updated: 09/29/2009 webteam@med.wisc.edu